In June 2022, Edenbridge Pharmaceuticals, LLC became a wholly-owned subsidiary of Dexcel Pharma. Dexcel Pharma is the largest private pharmaceutical company in Israel, commercializing an extensive portfolio of branded and generic drugs in Israel and various countries throughout the world.
We are pleased to announce that as of October 1, 2024, Edenbridge Pharmaceuticals, LLC is now doing business as Dexcel Pharma USA. This marks a major milestone on our path to unify our businesses under a single global brand with integrated resources, cementing our commitment to innovation and enhancing our ability to provide clinicians and patients with solutions to fulfill unmet needs across the world.
For more information, please contact the Company directly at info@dexcelpharmausa.com.